

CLASSIFICATION: MECHANO GROWTH FACTOR (MGF) PEPTIDE
ACTIVE SUBSTANCE: MGF IGF-1 EC
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 5–7 MINUTES (NATIVE), 20–30 MINUTES (PEG-MODIFIED)
DOSAGE: 200–400 MCG PER INJECTION (RESEARCH USE)
ACNE: NO
WATER RETENTION: MILD (RARE)
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
MGF IGF-1 Ec, also known as Mechano Growth Factor, is a splice variant of IGF-1 released in response to mechanical overload and muscle damage. It plays a key role in activating satellite cells and stimulating localized muscle hypertrophy. Peptide Hubs offers a 5 mg lyophilized version of high-purity MGF for advanced regeneration, recovery, and hypertrophy research.
MGF is produced by skeletal muscle in response to mechanical stress and microtrauma. It initiates satellite cell proliferation without differentiation, creating a reservoir of potential muscle cells. MGF differs from IGF-1 LR3 by acting locally and acutely during the early recovery window. For more details, refer to this NIH article on IGF-1 isoforms.
MGF is commonly combined with GHRP-2 for synergistic GH elevation or with GHK Basic for tissue regeneration. In studies focused on anti-aging and muscle repair, researchers also pair it with FOX04-DRI or BPC-157 for comprehensive cellular recovery support.
MGF IGF-1 Ec is intended strictly for research use only. It is not FDA-approved for human or veterinary use. Studies show low systemic side effects, short half-life, and limited risk of hormonal disruption or hepatotoxicity. Refer to ClinicalTrials.gov for emerging data on MGF-related peptides.
MGF IGF-1 Ec is studied for its role in activating satellite cells, promoting muscle regeneration, and supporting localized hypertrophy following physical stress.
MGF is a splice variant that acts locally and rapidly post-injury. IGF-1 LR3 has systemic and longer-acting effects. They differ in timing, target, and function.
MGF has minimal to no reported water retention. In rare cases with excessive doses, transient edema may occur in localized areas.
MGF is not approved for human consumption. It is sold strictly for research use in laboratory and preclinical settings.
Please log in to write MGF IGF-1 EC 5 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS